Neurofilament Light Chain as a Biomarker in Multiple Sclerosis

Frontiers in Neurology - Switzerland
doi 10.3389/fneur.2019.00338
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Frontiers Media SA

Related search

Vitamin D Supplementation and Neurofilament Light Chain in Multiple Sclerosis

Acta Neurologica Scandinavica
MedicineNeurology
2018English

Fingolimod and CSF Neurofilament Light Chain Levels in Relapsing-Remitting Multiple Sclerosis

Neurology
Neurology
2015English

Neurofilament Light Chain as Disease Biomarker in a Rodent Model of Chemotherapy Induced Peripheral Neuropathy

Experimental Neurology
Developmental NeuroscienceNeurology
2018English

Diagnostic Accuracy of CSF Neurofilament Light Chain Protein in the Biomarker-Guided Classification System for Alzheimer's Disease

Neurochemistry International
Molecular NeuroscienceCell BiologyCellular
2017English

Author Correction: Serum GFAP as a Biomarker for Disease Severity in Multiple Sclerosis

Scientific Reports
Multidisciplinary
2019English

Blood Neurofilament Light Chain at the Doorstep of Clinical Application

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2019English

Evaluating Optic Nerve Diameter as a Possible Biomarker for Disability in Patients With Multiple Sclerosis

Neuropsychiatric Disease and Treatment
2019English

Retinal Imaging With Optical Coherence Tomography: A Biomarker in Multiple Sclerosis?

Eye and Brain
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2018English

Deficiency in Ubiquitin Ligase TRIM2 Causes Accumulation of Neurofilament Light Chain and Neurodegeneration

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy